Pfizer Deutschland GmbH, Linkstraße 10, 10785 Berlin, Germany.
Pfizer Pharma GmbH, Linkstraße 10, 10785 Berlin, Germany.
Vaccine. 2021 Jan 29;39(5):830-838. doi: 10.1016/j.vaccine.2020.12.047. Epub 2021 Jan 4.
Tick-borne encephalitis (TBE) is an arboviral infection of the central nervous system. As there is no causal treatment of TBE, disease prevention by vaccination is especially important. Immunization consists of a three-dose primary vaccination schedule, followed by regular booster doses. In Germany, the Standing Committee on Vaccination (STIKO) at the Robert Koch-Institute recommends TBE vaccination for all those at high risk of contracting TBE. This includes individuals living in, traveling to and/or working in risk areas, and being exposed to ticks. To our knowledge, there are currently no reliable data on TBE vaccination rates in Germany available.
This retrospective cohort study based on anonymized German health claims data was conducted to determine vaccination rates of TBE primary immunization in 2012 to 2015 by federal state, compliance with the vaccination schedule, and TBE vaccination uptake for the 2011 birth cohort. Vaccination protection rates for each federal state were simulated based on a compartmental model.
Vaccination rates of an initiated primary immunization ranged from about 3% in the southern federal states to <1% in the northern federal states. Across all federal states, compliance with the vaccination schedule decreased with each subsequent vaccination. Slightly higher TBE vaccination uptake was determined in the 2011 birth cohort, as compared to the German school entry health examination statistics in 2017. Simulated vaccination protection rates for each federal state ranged from 10% in Hamburg to 51% in Baden-Wuerttemberg.
While there was an overall low vaccination uptake and a discrepancy between areas of high vs. low TBE risk, this study also indicates a concerning decline in vaccination compliance. Vaccinating physicians should address the importance of adherence upon initiation of TBE vaccination.
蜱传脑炎(TBE)是一种中枢神经系统的虫媒病毒感染。由于 TBE 没有因果治疗方法,因此预防疾病的疫苗接种尤为重要。免疫接种由三剂基础免疫接种方案组成,然后定期进行加强剂量接种。在德国,罗伯特科赫研究所(Robert Koch-Institute)的疫苗接种常设委员会(STIKO)建议所有 TBE 高危人群接种 TBE 疫苗。这包括居住在、前往和/或在疫区工作的人,以及接触蜱的人。据我们所知,目前尚无关于德国 TBE 疫苗接种率的可靠数据。
本回顾性队列研究基于匿名德国健康索赔数据,旨在确定 2012 年至 2015 年按联邦州、疫苗接种时间表的遵守情况以及 2011 年出生队列 TBE 疫苗接种率的 TBE 基础免疫接种率。基于房室模型模拟了每个联邦州的疫苗接种保护率。
启动基础免疫接种的疫苗接种率从南部联邦州的约 3%到北部联邦州的<1%不等。在所有联邦州,随着后续每次接种,疫苗接种时间表的遵守率下降。与 2017 年德国入学健康检查统计数据相比,2011 年出生队列中确定了略高的 TBE 疫苗接种率。模拟的每个联邦州的疫苗接种保护率从汉堡的 10%到巴登-符腾堡州的 51%不等。
尽管总体疫苗接种率较低,且高风险与低风险地区之间存在差异,但本研究还表明疫苗接种遵守率令人担忧地下降。接种疫苗的医生应在开始 TBE 疫苗接种时强调遵守的重要性。